Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Heart Failure
Search: search_blue_button Advanced Search
Circulation: Heart Failure. 2009;2:98-104
Published online before print February 10, 2009, doi: 10.1161/CIRCHEARTFAILURE.108.807271
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/2/98    most recent
CIRCHEARTFAILURE.108.807271v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patel, P. C.
Right arrow Articles by Markham, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patel, P. C.
Right arrow Articles by Markham, D. W.
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Remodeling
Right arrow Hypertrophy
Right arrowRelated Articles

Original Articles

Association of Cystatin C With Left Ventricular Structure and Function

The Dallas Heart Study

Parag C. Patel, MD; Colby R. Ayers, MS; Sabina A. Murphy, MPH; Ronald Peshock, MD; Amit Khera, MD, MSc; James A. de Lemos, MD; Jody A. Balko, MSc; Sachin Gupta, MD; Pradeep P.A. Mammen, MD; Mark H. Drazner, MD, MSc and David W. Markham, MD

From the Division of Cardiology (P.C.P., R.P., A.K., J.A.L., J.A.B., S.G., P.P.A.M., M.H.D., D.W.M.), Donald W. Reynolds Cardiovascular Clinical Research Center (C.R.A., R.P., A.K., J.A.L., M.H.D. D.W.M.), University of Texas Southwestern Medical Center, Dallas, Tex; and Brigham and Women’s Hospital (S.A.M.), Boston, Mass.

Correspondence to David W. Markham, MD, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, HA9.133, Dallas, TX 75390-9047. E-mail David.Markham{at}utsouthwestern.edu

Received July 16, 2008; accepted December 3, 2008.

Background— Cystatin C, a novel marker of renal function, has been associated with heart failure and cardiovascular mortality in older individuals. We tested the hypothesis that cystatin C is associated with preclinical cardiac structural and functional abnormalities in a younger population-based sample.

Methods and Results— The study included participants in the Dallas Heart Study (ages 30 to 65 years) who had measurements of cystatin C and cardiac MRI. The associations of cystatin C with left ventricular (LV) mass, LV end-systolic and -diastolic volumes, concentricity (LV mass/LV end-diastolic volume), LV wall thickness, and LV ejection fraction were evaluated. Cystatin C levels ranged from 0.46 to 6.55 mg/L. In univariable analyses, increasing levels of cystatin C correlated with higher LV mass, concentricity, and wall thickness (P<0.001), but not with LV end-systolic volume, LV end-diastolic volume, or LV ejection fraction. After adjustment with traditional covariates and estimated glomerular filtration rate by the modification of diet in renal disease formula, log-transformed cystatin C remained independently associated with LV mass (P<0.001), concentricity (P=0.027), and wall thickness (P<0.001). These associations persisted when creatinine or estimated glomerular filtration rate by the Cockcroft-Gault formula were included in the models.

Conclusions— Higher levels of cystatin C were associated with increased LV mass and a concentric LV hypertrophy phenotype. These findings were independent of potential confounding variables including standard measurements of renal function, supporting the hypothesis that cystatin C may be useful to identify individuals with preclinical structural heart abnormalities.

Key Words: cystatin C • concentricity • left ventricular hypertrophy • hypertension • renal function • Dallas Heart Study


 

CLINICAL PERSPECTIVE


Related Articles

Serum Cystatin C, Renal Filtration Function, and Left Ventricular Remodeling
Mark D. McMurray, Justin E. Trivax, and Peter A. McCullough
Circ Heart Fail 2009 2: 86-89. [Extract] [Full Text] [PDF]

Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study
Parag C. Patel, Colby R. Ayers, Sabina A. Murphy, Ronald Peshock, Amit Khera, James A. de Lemos, Jody A. Balko, Sachin Gupta, Pradeep P.A. Mammen, Mark H. Drazner, and David W. Markham
Circ Heart Fail 2009 2: 98-104. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Circ Heart FailHome page
M. D. McMurray, J. E. Trivax, and P. A. McCullough
Serum Cystatin C, Renal Filtration Function, and Left Ventricular Remodeling
Circ Heart Fail, March 1, 2009; 2(2): 86 - 89.
[Full Text] [PDF]